CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma

Hepatology International

Volumn 10, Issue 3, 2016, Pages 488-492

  Li, YueGuo ^a   Yu, Hai Peng ^a   Zhang, Peng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

CCL15; Hepatocellular carcinoma; Immunohistochemistry; Survival time

Indexed keywords

ALPHA FETOPROTEIN; CCL15 PROTEIN; CHEMOKINE; UNCLASSIFIED DRUG; BETA CHEMOKINE; CCL15 PROTEIN, HUMAN; MACROPHAGE INFLAMMATORY PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR THROMBUS; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; KAPLAN MEIER METHOD; LIVER; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOKINES, CC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84949513667     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-015-9683-4     Document Type: Article

References (14)

1. Zhang Y, Fan Y, Mei Z. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification. Cancer Epidemiol. 2012;36(5):e294–9.
2. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–46.
3. Singh S, Sadanandam A, Singh RK. Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev. 2007;26:453–67.
4. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50–6.
5. Li Y, Wu J, Zhang W, et al. Identification of serum CCL15 in hepatocellular carcinoma. Br J Cancer. 2013;108(1):99–106.
6. Youn BS, Zhang SM, Lee EK, et al. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol. 1997;159:5201–5.
7. Hwang J, Kim CW, Son KN, et al. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett. 2004;570:47–51.
8. Pardigol A, Forssmann U, Zucht HD, et al. HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. Proc Natl Acad Sci USA. 1998;95:6308–13.
9. Ko J, Kim IS, Jang SW, et al. Leukotactin-1/CCL15-induced chemotaxis signaling through CCR1 in HOS cells. FEBS Lett. 2002;515:159–64.
10. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108–15.
11. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol. 2000;72:391–8.
12. Kunz M, Hartmann A, Flory E, et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol. 1999;155:753–63.
13. Desbaillets I, Diserens AC, Tribolet N, et al. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med. 1997;186:1201–12.
14. Itatani Y, Kawada K, Fujishita T, et al. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Gastroenterology. 2013;145(5):1064–75.